ODF3B

Across TCGA pan-cancer cohorts, ODF3B mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ODF3B data layer compared with 24 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher ODF3B mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated ODF3B expression acts as an unfavorable survival marker.

LUAD, HNSC, and LSCC are the cancer types where ODF3B mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	III,IV	0.543	0.937	.005	17	view →
HNSC	DFS	Quartile	II,III,IV	0.517	0.788	.025	2	view →
LSCC	OS	Tertile	II,III,IV	0.880	1.000	.043	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

ODF3B–LUAD (DFS)

Open the LUAD breakdown →